Overview
Govinda Sharma practices practicing medicine in Calgary, Canada.
His clinical expertise encompasses Optic Nerve Atrophy, Acute Cerebellar Ataxia, and Charcot-Marie-Tooth Disease.
He is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Govinda Sharma
Is Govinda Sharma a top-rated expert for Optic Nerve Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Govinda Sharma is classified as an Experienced expert for Optic Nerve Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Govinda Sharma participate in research or clinical trials?
Yes. Govinda Sharma has published 9 articles and abstracts on conditions like Optic Nerve Atrophy. You can view a list of Govinda Sharma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Cerebellar AtaxiaMr. Sharma isExperienced. Learn about Acute Cerebellar Ataxia.
- Charcot-Marie-Tooth DiseaseMr. Sharma isExperienced. Learn about Charcot-Marie-Tooth Disease.
- Optic Nerve AtrophyMr. Sharma isExperienced. Learn about Optic Nerve Atrophy.